Federation Des Caisses Desjardins Du Quebec Bio N Tech Se Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.9 Billion
- Q3 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Bio N Tech Se stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 471 shares of BNTX stock, worth $58,545. This represents 0.0% of its overall portfolio holdings.
Number of Shares
471
Previous 376
25.27%
Holding current value
$58,545
Previous $30,000
83.33%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding BNTX
# of Institutions
358Shares Held
38.5MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$1.03 Billion0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$561 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$542 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$236 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$225 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $30.2B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...